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Adenylate cyclase and cell cyclic AMP of rat cortical thick ascending
limb of Henle. Effects of parathyroid hormone (PTH), calcitonin (CT).
vasopressin (VP), and glucagon (GL) on adenylate cyclase activity and
cyclic AMP (cAMP) levels in isolated cortical thick ascending limbs of
Henle's loop (CTAL) of the rat kidney were examined. PTH, CT, and
VP each stimulated adenylate cyclase of this nephron segment in a
dose-dependent manner. Stimulation of the enzyme activity was great.
est with a maximal dose of PTH and least with VP. With maximal
doses, the effects of PTH and CT were not additive; whether or not the
effects of maximal doses of VP and PTH or CT were additive was not
clear. All three hormones increase cAMP in intact CTAL in a dose-
dependent manner. Maximal doses of PTH, CT, VP, and GL resulted in
comparable rises in cell cAMP, and there was no additive effect. These
data suggest that PTH and CT may stimulate the same adenylate
cyclase moieties, whereas VP may stimulate distinct enzyme moieties,
and that these three peptide hormones as well as GL definitely act on
the same cell group in rat CTAL. Thus, it is possible that these
hormones may induce qualitatively similar effects on CTAL functions if
such effects are mediated by cAMP.
Adenylate cyclase et AMP cyclique cellulaire de Ia branche ascendante
large de l'anse de Henle chez le rat. Les effets de l'hormone parathyrol-
dienne (PTH), de Ia calcitonine (CT), de Ia vasopressine (VP) et du
glucagon (GL) sur l'activité adenylate cyclase et Ia concentration de
cAMP dans des anses ascendantes larges corticales de Henle (CTAL)
du rein de rat ont été étudiés. La PTH, Ia CT, et Ia VP stimulent
individuellement l'adénylate cyclase de ce segment d'une facon dépen-
dante de Ia dose. La stimulation maximale de l'activité enzymatique est
Ia plus grande avec la PTH et moindre avec VP. A concentrations
maximales, les effets de La PTH et de Ia CT ne sont pas additifs; il n'est
pas clairement établi que les effets de concentrations maximales de VP
et de PTH ou de VP et de CT sont ou non additifs. Les trois hormones
augmentent cAMP dans le CTAL intact d'une facon dépendante de Ia
concentration. Des concentrations maximales de PTH, de CT, de VP,
et de GL déterminent des augmentations de concentration comparable
de cAMP cellulaire et il n'y a pas d'additivité. Ces résultats suggérent
que Ia PTH et Ia CT pourraient moduler les mémes fractions d'adény-
late cyclase alors que Ia VP stimulerait une fraction distincte, et que ces
trois hormones peptidiques de méme que GL agissent sur le méme type
cellulaire du CTAL du rat. Ainsi il est possible que ces hormones
puissent induire des effets qualitativement similaires sur les fonctions
du CTAL si ces effets ont le cAMP pour mddiateur.
Each nephron segment has distinct transport characteristics
and hormone sensitivity. The distribution of adenylate cy-
clase's sensitivity to parathyroid hormone (PTH), calcitonin
(CT), vasopressin (VP), and beta adrenergic agonists has been
described by the ultramicroassay of adenylate cyclase in isolat-
ed single nephron segments of rabbits, mice, rats, and of man
[1—7]. In the thick ascending limb of Henle's loop (TAL), PTH
has been shown to stimulate adenylate cyclase activity in the
cortical portion (CTAL) of rabbit, mouse, rat, and human
kidneys, whereas this hormone has no effect on the enzyme
activity of the medullary portion (MTAL) of rabbit, mouse, and
rat kidneys [6]. By contrast, CT stimulates the enzyme activity
in both MTAL and CTAL of rabbit and human kidneys, but it
has minimum effects on adenylate cyclase of mouse CTAL and
MTAL [7]. VP also stimulates the enzyme activity of both
MTAL and CTAL of mouse kidney and to a lesser extent that of
both segments of rabbit kidney [7]. In addition, a recent si:udy
showed the presence of glucagon (GL) -sensitive adenylate
cyclase in CTAL of rat kidney [8]. Although the physiologic
significance of these hormones in TAL is not known, adenylate
cyclase's sensitivity to more than one hormone in one nephron
segment raises a possibility that these hormones may exert
similar biological effects if such effects are mediated by cAMP.
To entertain such a possibility, one must know whether these
hormones act on the same adenylate cyclase moiety and on the
same tubular cells. Effects of multiple agonists on adenylate
cyclase activities will provide information on whether or not
they act on the same or different enzyme moieties: If effects of
hormones at maximal concentrations are nonadditive, it follows
that they stimulate the same enzyme moiety and thus musi act
on the same cells. If multiple agonists act on distinct cell
groups, their effects on cell cAMP contents must be additive,
whereas if they act on the same cell group, the effects are either
additive or nonadditive. Thus, the lack of additive effects will
provide useful information [7]. Accordingly, we examined the
effects of PTH, CT, VP, and GL on adenylate cyclase activity
and on the levels of cell cAMP in rat CTAL.
Methods
Wistar male rats weighing 100 to 300 g were used in the
present study. Hormones used were parathyroid hormone
(PTH; 1—34 amino acids bovine synthetic PTH, 6,000 U/mg,
Beckman Co., Palo Alto, California), synthetic salmon calcito-
nm (CT; 4,000 U/mg, Armour Pharmaceutical Co., Scottsdale,
Arizona), synthetic arginine vasopressin (VP; grade VI, Siigma
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Chemical Co., St. Louis, Missouri), and glucagon (OL; Eli Lilly
& Co., Indianapolis, indiana). In some experiments, parathy-
roid extract (PTE; Parathyroid Injection USP, Eli Lilly & Co.,
Indianapolis, Indiana) was used.
Preparation of isolated single nephron segments and assay of
adenylate cyclase activity. Rats were anesthetized by i.p.
injection of pentobarbital, 40 mg/kg body wt. The right renal
and superior mesenteric arteries were ligated, and the left
kidney was perfused, through a PE-l0O catheter inserted in the
abdominal aorta below the renal arteries, over a few seconds
with 5 ml of chilled Krebs-Ringer-bicarbonate (KRB) buffer:
105 m sodium chloride, 5 m potassium chloride, 25 mM
sodium bicarbonate, 10 m sodium lactate; I .0 mrvi monobasic
and dibasic sodium phosphate, 1,0 mivi magnesium chloride,
and 1.0 mri calcium chloride (pH 7.4) with 8.3 m glucose,
equilibrated with 95% oxygen and 5% carbon dioxide (vol/vol)
followed by a rapid perfusion over 5 to 10 sec with 10 ml of ice-
cold KRB buffer containing 8.3 m glucose, 10 mg of collage-
nase (type I, #69C-0354, Sigma Chemical Co., St. Louis,
Missouri), and 10 mg of bovine serum albumin (BSA; KRB-
BSA-collagenase). Immediately before the perfusion of the left
kidney, the aorta was clamped above the left renal artery.
The left kidney was removed, and slices of kidney tissue
(approximately 0.5 to 1.0 mm in thickness) cut in the cortico-
medullary plane were incubated at 30° C for 30 mm in KRB-
BSA collagenase with 95% oxygen and 5% carbon dioxide (vol/
vol) as a gas phase. Kidney slices were rinsed with 50 ml of ice-
cold, calcium-free Hanks' solution: 137 m sodium chloride,
5.3 msi potassium chloride, 0.34 mrvi dibasic sodium phosphate,
0.44 mM monobasic potassium phosphate, 4.2 m sodium
bicarbonate, 0.42 mrt magnesium sulfate, and 0.49 m magne-
sium chloride (pH 7.4). Tubule segments were dissected from
cortex (CTAL) and from outer medulla (MTAL) under the
stereomicroscope in an ice-cold, calcium-free Hanks' solution.
Each dissected tubule segment was transferred to a siliconized
individual well of a serological slide, and the tubule length was
measured with an aid of a drawing tube attached to the
microscope (Wild M5 dissecting microscope). Adenylate cy-
clase activity in isolated nephron segments was assayed by the
method described by Imbert et a! [1] with modifications de-
scribed earlier [9]. After careful aspiration of the dissecting
medium bathing the tubules, I pi of hypotonic preincubation
solution (8 mrvi Tris hydrochloride buffer (pH, 7.4), 1 mM
magnesium chloride, 0.25 m EDTA-sodium, and 0.1% BSA)
was added. This preincubation solution contained appropriate
test hormone(s) or vehicle at concentrations five times greater
than those indicated in the results as final concentrations [1—3].
After 30 mm of preincubation at 0° C, tubule segments were
freeze-thawed twice. Then, 4 l of incubation medium was
added consisting of 100 msi Tris hydrochloride buffer (pH, 7.4),
3.8 mi magnesium chloride, 0.25 msi EDTA-sodium, 1.35 mM
l-methyl-3-isobutylxanthine (MIX), 0.6 mM ATP, 20 mM phos-
phocreatine, and 1 mg/mI creatine phosphokinase (140 U/mg,
Sigma Chemical Co., St. Louis, Missouri), and the incubation
was carried out at 30° C for 30 mm.
The incubation was terminated by the addition of 10 il of 0.2
N hydrochloric acid followed by the successive addition of 10 ixl
0.2 N sodium hydroxide and 200 .d of 50 m sodium acetate
buffer (pH, 6.2). An aliquot of the resultant mixture was
assayed for cAMP, after acetylation of cAMP, by the radio-
immunoassay (RIA) using a highly specific antibody toward
succinyl-cAMP as reported earlier [9]. In brief, RIA was
performed in 200 l1 of 50 mM sodium acetate buffer (pFI, 6.2),
containing approximately 10,000 cpm '25l-cAMP (specific activ-
ity, about 250 Ci/mmole; New England Nuclear, Boston, Mas-
sachusetts), rabbit anti-succinyl cAMP antibody prepared in
our laboratory diluted to bind 50 to 60% of '251-cAMP in the
absence of added cold cAMP, and standard cAMP or samples
both acetylated immediately prior to assay. After overnight
incubation at 4° C, the cAMP-antibody complex was separated
by adding 60% ammonium sulfate followed by a centrifugation
at X2,000g for 25 mm at 4° C. Significant displacement of 1251
cAMP was detectable with the addition of 10 fmoles of nonla-
beled cAMP, and the standard curves were linear between 10
and 500 fmoles of nonlabeled cAMP added and plotted on the
semi-log scale. Samples were accordingly prepared to contain
10 to 500 fmoles of cAMP per assay. The accuracy of RIA was
checked by (I) the linearity of assays after serial dilutions of
samples, (2) the complete disappearance of the immunoreactiv-
ity by phosphodiesterase treatment, (3) the lack of effects on
RIA of any component of the incubation mixture at concentra-
tions used, and (4) linear positive correlations (P < 0.01)
between the tubular length and cAMP formed. Further, the
purification of cAMP by column chromatography followed by
the precipitation of zinc sulfate and barium hydroxide [10] gave
comparable values of cAMP determined by the RIA.
Results were expressed as femtomoles of cAMP formed per
millimeter of tubule length per 30 mm.
Incubation and assay of cyclic AMP in intact tubule seg-
ments. Modified Hanks' solution containing 1.0 mrvi calcium
chloride, 1.2 mrvi MIX, and 0.25% BSA was used for both
dissection and incubation of isolated nephron segments. In
some experiments, MIX was either omitted or reduced to 0.12
m. Two to five single nephron segments (total length, 2 to 6
mm) were transferred in 20 pi of dissecting medium to a center
of a siliconized flat-bottom glass scintillation vial (17 x 52 mm),
and the length of the tubules was measured through a drawing
tube attached to the microscope as described above. After 5
mm of preincubation at 37° C, 20 xl of modified Hanks' solution
containing appropriate text hormone(s) or vehicle was added to
the incubation medium, and the incubation was continued for
an additional 2 mm at 37° C. The incubation was terminated by
the addition of 50 xl 10% trichloroacetic acid (TCA), and the
mixture was vortexed, extracted three times with 0.8 ml of
ether saturated with water. The residual aqueous phase was
dried at 40 to 450 C, and the vials were kept at —20° C until the
assay.
Immediately prior to the assay, 100 p.1 of 50 mi'vt sodium
acetate buffer, (pH, 6.2) was added to each vial, mixed, and the
extracts were assayed for cAMP after acetylation by RIA.
Recovery of 3H-cAMP added together with TCA was 93 to
102%. Linear relations were observed between the tubular
length and cAMP formed by the intact tubules as depicted in
Fig. I. When the extracts of tubules incubated with agonists
thus containing varying amounts of cAMP were divided and
assayed for cAMP with or without additional 100 fnioles of
cAMP, the measured values for added cAMP were 101.8 6.4
(N = 9). Values of 105.4 3.7 (N = 5) were obtained for the
same amount (100 fmoles) of cAMP when assayed without
tubular extracts. Values of cAMP obtained in TCA extracts
purified further for cAMP by column chromatography followed
by the zinc sulfate and barium hydroxide precipitation [10]
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Fig. 1. Relation between cAMP formed and the tubule length per
incubation. In this experiment, intact proximal convoluted tubules with
varying length were incubated for 2 mm with 2 U/mI PTH. TCA extracts
were dried, resuspended in 125 l of sodium acetate buffer, and 50 l
aliquots were assayed for cAMP. V = 25.7x + 1.5, r = 0.975, P <0.001.
See text for details.
agreed within less than 10% with those without purification
procedures.
In separate experiments, the time-course changes in cAMP
contents in tubule cells and in the incubation medium were
measured. After 5 mm of preincubation at 37° C, the test
hormone was added as described above. At 2 and 10 mm (12
mm for PTE experiments) after the hormone addition, 200 til of
ice-cold isotonic saline containing 1.2 mtvi MIX was added to
the incubation vial, which was then centrifuged for 2 mm at
xl .000g at 4° C. An aliquot (100 111) of the upper portion of the
medium was carefully transferred to another vial, and to both
vials, one containing tubules and the incubation medium and
another with the medium only, 20 p.1 of 50% TCA was added.
After extracting TCA with ether saturated with water as de-
scribed above, we dried the extract, resuspended it in 100 p.1 of
50 m sodium acetate buffer (pH. 6.2) and assayed it for cAMP
by RIA. Intracellular cAMP contents were calculated as the
difference between cAMP values in the tubules plus medium
and those in the medium. The addition of isotonic saline
solution containing MIX was without significant effect on the
RIA. Results are expressed as femtomoles of cAMP per milli-
meter of tubule length.
Results were expressed as the means SEM and were
analyzed using Student's t test.
Results
Dose—response relationship between PT/I, CT, and VP, and
adenylate cyclase activity of CTAL. As shown in Fig. 2, PTH,
CT, and VP all stimulated adenylate cyclase activity of CTAL
in a dose-dependent manner. By contrast, PTE was without
effect on the enzyme activity of MTAL, whereas CT and VP
stimulated it (Table I). In general, with maximal doses PTH
stimulated adenylate cyclase of CTAL to a greater extent than
did CT or VP, and VP-stimulated enzyme activity was smallest
800
600
400
200 7 7
0 !r. .0 .01 .1 1 10 0 .001 .01 .1 1 0 11 10 9 8 7
PTH, U/mi CT, U/mi VP, —/0gM
Fig. 2. Dose-dependent activation by PTH, CT. and VP of adenvlate
cyclase of rat CTAL. Each point represents the mean (± 5EM) of 4 to 8
incubations.
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VP, 5 X l0 M 336 16(5)
in this segment. VP, however, exerted a greater enzyme
stimulation than did CT in MTAL.
Effects of maximal doses of hormones on adenylate cyc/ase
activity of CTAL. Effects of maximal doses of PTH. CT, and VP
in various combinations on adenylate cyclase activity in CTAL
are summarized in Table 2. Considerable variations in the
magnitude of enzyme stimulation among experiments are ob-
served as already reported [1—6j. With both PTH and CT
together, the increments in the enzyme activity were not greater
than those with PTH or CT alone. The addition of VP with PTH
or CT resulted in enzyme activities not different from those
seen with PTH or CT alone. A much smaller magnitude of
enzyme activation by VP than that by PTH or CT may have
masked the presence of possible additive effects of VP with
PTH or CT, however. The addition of three hormones together
resulted in the enzyme activity again not different from that
seen by PTH, which gave the greatest enzyme stimulation.
Time-course changes in cyclic AMP in CTAL and in the
incubation medium. As shown in Fig. 3, tubular cAMP levels
rose rapidly in response to hormone addition, and at 2 mm only
a minor fraction of cAMP was in the incubation medium. Al 10
mm (or at 12 mm for PTE) after the addition of test hormones,
cAMP in the incubation medium rose considerably so that total
cAMP (tubules plus incubation medium) at 10 mm became
greater than that at 2 mm. Intracellular cAMP levels at lO mm
were not different from those obtained at 2 mm, however.
Dose-response relation between PTH, CT, VP, and ,ell
cyclic AMP levels of CTAL. The dose-response relationships
between PTH, CT, VP, and cell cAMP of intact CTAL are
shown in Fig. 4. Increments in cell cAMP depicted in this Fig. 4
are mostly those occurring intracellularly because values repre-
sent total cAMP measured at 2 mm after hormone addition.
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Table 1. Effects of parathyroid extract (PTE), calcitonin (CT).
and vasopressin (VP) on activity of medullary thick ascending limbs
of Henle
cAMP formed, fmoles/mm/30 mm
Values are the means SEM with the number of incubations in
parentheses.
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Table 2. Effects of maximal doses of parathyroid hormone (PTH), calcitonin (CT), and vasopressin (VP) on adenylate cyclase activity of rat
cortical thick ascending limb of Henlea
Adenylate cyclase activity, fmoles cAMP formed per mm/30 mm
Additions Exp. 1 Exp. 2 Exp. 3 Exp. 4 Exp. 5 Exp. 6 Exp. 7 Exp. 8
None (control)5
PTH, 10 U/ml
CT, 0.1 U/mI
VP, 10 M
PTH + CT
PTH + VP
CT + VP
PTH + CT + VP
34,1 4.7 (21)
834 137 (5)
442 41(5)
201 26 (5)
1052 165 (5)
839 64 (6)
652 86 (5)
918 51(5)
551
332
152
503
605
400
747
97 (4)
127 (5)
32 (5)
127 (4)
162 (5)
124 (5)
155 (6)
451 34 (8)
—
202 48 (6)
—
502 38 (8)
—
—
—
851 105 (5)
357 68 (5)
—
—
824 162 (5)
—
—
434 65 (5)
160 16(5)
—
—
692 104 (5)
—
—
723 75 (5)
118 17 (5)
—
689 84 (5)
817 95 (9)
577 75 (8)
—
754 60 (10)
—
460 38 (7)
336 52 (5)
—
401 34 (6)
—
a Values are the mean SEM with the number of incubations in parentheses.
bControl values were comparable in these and other experiments and were not measured in every experiment listed here. Thus, all values were
combined.
'PTH = 5 U/mI.
vp activity. This difference is apparent in data shown in Figures 2
,'X and 4.
Effect of graded concentrations of l-methyl-3-isobutylxan-
rhine on cell cyclic AMP levels. Although PTH and CT elicited
greater adenylate cyclase activation than VP did, differences in
the increments in cell cAMP by these hormones were much
smaller compared with the differences observed in adenylate
cyclase activation. Indeed, in most experiments, these three
peptide hormones increased cell cAMP to comparable levels.
Such apparently discrepant effects of agonists on adenylate
cyclase and on cell cAMP levels may be due to a possible
presence of some metabolic factor in the intact cell preparation,
such as ATP availability for adenylate cyclase, which may
become limiting in cell cAMP accumulation. To evaluate such a
possibility, we examined increments in cell cAMP in the
absence and in the presence of graded inhibition of phosphodi-
esterase activity. As shown in Table 3, increments in cell cAMP
in response to hormone addition were minimal in the absence of
a phosphodiesterase inhibitor, MIX. In the presence of either
0.12 or 1.2 mrvi MIX, cell cAMP rose to comparable levels in
response to maximal doses of PTH, CT, or VP. But, cAMP
levels rose to higher levels with 1.2 ma'i MIX than they did with
0.12 mrvt MIX.
Effects of various combinations of maximal doses of hor-
mones on cell cyclic AMP. As shown in Tables 3 and 4, levels of
cell cAMP in response to these hormones added in various
combinations were not greater than those to each hormone
added separately. A recent study by Bailly et a! [8] showed the
presence of glucagon (GL) -sensitive adenylate cyclase in TAL
of rat kidney, and therefore, the effects of GL on cell cAMP
were also examined. As shown in Table 5, no additive effects
were observed in increments in cell cAMP in response to PTH,
VP, and GL in CTAL; effects of VP and GL on cell cAMP in
MTAL were also not additive (Table 5).
Discussion
The present study confirmed and extended previous observa-
tions by Morel, Chabardes, and Imbert [71. Maximal enzyme
activation of CTAL was obtained at hormone concentrations of
5 U/mI, 0.1 U/mI, and 108 M for PTH, CT, and VP, respective-
ly. The magnitude of enzyme activation of CTAL with maximal
hormone concentrations was greatest with PTH followed by
CT, then VP. There is a clear distinction in hormone respon-
siveness of adenylate cyclase between cortical and medullary
PTE CT
I
30
20 / //
10 2 10
Time. rn/fl
FIg. 3 Distribution of cAMP in the tubules and incubation medium.
Intracellular cAMP levels (•---•) were calculated from those in the
incubation medium plus tubules (O---O) and those in the incubation
medium only (D---D). Cyclic AMP levels at 0 time were very low, and
only total cAMP could be measured (0.6 0.3, N = 15). Concentrations
of hormones used were 0.5 U/mI, 0.1 U/mI, and l0 M for PTE, CT,
and VP, respectively. Each point represents the mean (± 5EM) of
quintuplicate incubations. See text for details.
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Fig. 4. Dose-dependent increases in cell cAMP levels in response to
PTH, CT, and VP in intact CTAL. After 5 mm of preincubation, the
intact CTAL were incubated for 2 mm with varying concentrations of
test hormones. Each point represents the mean (± 5EM) of 4 to 8
incubations.
The doses of hormones that increase cell cAMP to a half
maximal and a maximal level were similar to those that activate
adenylate cyclase in this nephron segment for CT and VP. But,
doses of PTH causing half-maximal stimulation were consis-
tently lower for cell cAMP than they were for adenylate cyclase
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Table 3. Effects of MIX on cell cyclic AMP levels in response to parathyroid hormone (PTH), calcitonin (CT), and vasopressin (VP)°
Additions
Cell cyclic AMP, fmoleslmm
0 mi MIX 0.12 mri MIX 1.2 mM MIX
None (control)
PTH, 10 U/mI
CT, 0.1 U/mI
VP, 10-8 M
0.6
3.5
1.3
3.2
0.2 (10)
1.0 (5)
0.7 (5)
0.5 (5)
NTb
23.5 3.7 (5)
27.2 3.2 (5)
21.2 1.6 (5)
NV'
51.1 1.7 (3)
45.4 10.4 (3)
45.6 11.2 (3)
a Values are the mean SEM with the number of incubations in parentheses. Isolated cortical thick ascending limbs of Henle were incubated in
the presence or absence of MIX for 5 mm at 37° C. Then hormones were added at final concentrations indicated, and the incubation was carried out
for an additional 2 mm. The results represent data obtained in the CTAL dissected from the same rat. See text for details.
bNot tested in these experiments. In other experiments, however, values with 1.2 mri MIX were always less than 10 fmoles/mm, and with 0.12
mM MIX less than 4 fmoles/mm.
Table 4. Effects of maximal doses of parathyroid hormone (PTH), calcitonin (CT), and vasopressin (VP) on cyclic AMP levels in intact cortical
thick ascending limbs of Henle of rat kidney°
Additions
Cell cyclic AMP, fmoles/mm
Exp. I Exp. 2 Exp. 3 Exp. 4
None (control)"
PTH, 10 U/mI
CT, 0.1 U/mI
VP, 10 M
PTH + CT
PTH + VP
CT + VP
PTH + CT + VP
0.6
15.3
13.0
11.5
12.2
14.4
13.5
0.3 (15)
1.5 (4)
1.7 (4)
0.9 (4)
0.5 (4)
1.2 (4)
—
1.5 (4)
36.7
29.4
30.3
28.6
27.5
—
38.1
3.8 (4)
1.2 (5)
2.6 (5)
2.9 (5)
1.5 (5)
2.5 (5)
—
15.8 1.2 (5)
12.2 0.9 (5)
—
—
13.6 0.8 (5)
—
15.8
26.2
—
—
26.7
—
1.6 (5)
2.5 (5)
2.4 (8)
° Values are the mean SEM with the number of incubations in parentheses.
b Control values were comparable in these and other experiments and were not measured in every experiment listed here. Thus, all values were
combined.
portions of TAL; in MTAL, the magnitude of enzyme activa-
tion was greater with VP than with CT, and PTH was without
effect.
Data shown in Table 2 suggest that PTH and CT may
stimulate the same adenylate cyclase moieties because the
addition of maximal doses of both hormones together demon-
strate a similar stimulation of enzyme activity that obtained in
each hormone added separately. The data are in accord with
those reported by Morel et at [IIj. A much smaller magnitude of
enzyme activation by maximal doses of VP makes the presence
of additivity with VP together with PTH and/or CT inconclu-
sive. Thus, whether VP also stimulates the same adenylate
cyclase moieties responsive to PTH and CT is not clear. The
presence of rather large intra- and inter-experiment variation
coefficients in the present study is similar to that observed by
Morel et a! [1—61, but explanations for such variations are not
immediately clear, It is possible that some conditions in individ-
ual animals or in experimental procedures may affect hormone
responsiveness. But, in the present study we did not attempt to
subject rats to specific pretreatments such as thyroparathyroid-
ectomy, dehydration, and so on, prior to the experiments,
procedures that might affect hormone-sensitive adenylate cy-
clase activities.
In the present study, we were able to detect changes in cell
cAMP in intact single nephron segments dissected from rat
kidney. Increments in cell cAMP at 2 mm after the hormone
addition were limited almost exclusively to the intracellular
spaces. At 10 mm after the hormone addition, however, up to
64% of total cAMP measured in the tubules and incubation
medium represents extracellular cAMP (Fig. 3).
Table 5. Effects of glucagon on cell cyclic AMP levels in intact
cortical and medullary thick ascending limbs of Henle of rat kidneya
Additions
Cell cyclic AMP, fmoles/mm
Exp. 1 Exp. 2 Exp. :3
Cortical TAL
None (control) 4.4 0.8 (4) 7.7 0.2 (4) 2.8 4 (3)
Glucagon, l0 M 53.3 6.9 (4) 48.3 4.8 (4) 38.0 2.9 (4)
VP, l0_8 M 39.1 3.8 (4) — 38.9 2.3 (4)
PTH, 10 U/mI 34.4 1.5 (4) 36.2 3.0 (4) —
GL + VP 56.2 6.3 (4) — 47.5 2.2(4)
GL + PTH 38.5 6.3 (4) 46.4 4.2 (4) —
Medullary TAL
None (control) 2.0 0.5 (3) 2.2 1.1 (3)
Glucagon, l0 M 14.7 2.3 (4) 16.0 2.0 (4)
VP, l0 M 15.2 1.3 (4) 21.2 1.1 (4)
GL + VP 15.3 1.4 (4) 23.2 3.1 (4)
a Values are the means SEM, with the number of incubations in
parentheses.
In contrast to greater stimulation of adenylate cyclase by
maximal doses of PTH and CT than that of VP, the magnitude
of increments in cell cAMP by maximal doses of PTH, CT, and
VP was similar. The reason for this apparent discrepant effect
of these hormones on adenylate cyclase activation and on rises
in cell cAMP is not clear. In contrast to the assay of adeny late
cyclase activity where the substrate, ATP, is provided in far
excess of the reaction product, cAMP, some metabolic factors
may limit the production of cAMP in intact cells despite
maximal stimulation of adenylate cyclase. Stated in anolher
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way, maximal increments in cell cAMP in the presence of
maximal hormone concentrations may be limited by some
factors other than adenylate cyclase activity. Such a factor may
include availability of ATP for adenylate cyclase. Although
levels of cell ATP are far in excess of cAMP when measured in
the whole kidney (approximately 1000 to 1 [12—141), it is
possible that ATP available for adenylate cyclase in CTAL may
easily become limited under hormonal stimulation. But, as
shown in Table 3, increments in cell cAMP in response to
maximal concentrations of PTH, CT, and VP were similar in
both the presence and the absence of phosphodiesterase inhibi-
tor. Moreover, in the presence of 1.2 mM MIX, these cells can
produce as much as 40 to SO fmoles/mm cAMP in 2 mm; that is,
this much ATP must be available for cAMP production. None-
theless, all three hormones could increase cell cAMP up to 30
fmoles/mm in 2 mm in the presence of a lower concentration of
the inhibitor. These data suggest that even under the condition
where ATP is unlikely to be a limiting factor in cell cAMP
production, maximal doses of PTH, CT, and VP increased cell
cAMP to comparable levels. We do not know at present the
reason for the apparent discrepant effects of maximal doses of
PTH, CT, and VP on adenylate cyclase activity and on cell
cAMP contents.
The addition of maximal doses of PTH, CT, VP, and GL in
various combinations clearly failed to increase cell cAMP
beyond those observed with each hormone added separately
(Tables 3, 4, and 5). Also, the effects of VP and GL on cell
cAMP of intact MTAL were not additive (Table 5). If these
hormones are acting on separate cell groups in TAL, one would
expect additive effects of maximal doses of these hormones on
cell cAMP contents. Thus, the lack of additive effects on cell
cAMP strongly suggests that these hormones act on the same
cell group in this nephron segment. Available morphologic
evidence suggests that the cell population in CTAL primarily
consists of one major cell type characterized by numerous and
prominent microvilli on the luminal surface [15].
If these four different peptide hormones are to act on the
same cells in CTAL, one might expect that they may have
qualitatively similar effects on the CTAL functions, assuming
such tubular functional responses are mediated by cAMP.
Similar conclusions could also be drawn for the actions of VP
and GL on MTAL, as both hormones seem to act on the same
cells in MTAL. At present, the physiologic significance of
adenylate cyclase in CTAL sensitive to these hormones is not
known. Recent studies using the isolated tubule perfusion
technique demonstrated stimulation of calcium reabsorption in
CTAL by PTH and dibutyryl cAMP 116—181. If such effects of
PTH on calcium transport are mediated by cAMP, one might
expect that CT, VP, and GL may also show qualitatively similar
effects on calcium transport in this nephron segment. It is of
note that these perfusion studies with isolated CTAL are
performed in the rabbit nephron and that the present results
were obtained in the rat nephron. Nonetheless, in the CTAL of
rat and rabbit kidneys, PTH, CT, and VP all can stimulate
adenylate cyclase. Thus, it is of interest to examine whether
these peptide hormones have similar effects on tubular function
in CTAL of rabbit and rat kidneys. If these hormones demon-
strate distinctly different or even opposite effects on CTAL
functions, then it follows that such tubular responses are not
mediated solely by cAMP and that some other cellular events
must he operative as a mechanism of hormone action.
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